EKF Diagnostics (OTCMKTS:EKDHF) Shares Up 0.9% – Should You Buy?

Shares of EKF Diagnostics Holdings plc (OTCMKTS:EKDHFGet Free Report) traded up 0.9% during trading on Tuesday . The stock traded as high as $0.3431 and last traded at $0.3431. 20,000 shares changed hands during mid-day trading, a decline of 6% from the average session volume of 21,293 shares. The stock had previously closed at $0.3402.

EKF Diagnostics Trading Up 0.9%

The company has a fifty day moving average price of $0.37 and a 200-day moving average price of $1,512.68.

About EKF Diagnostics

(Get Free Report)

EKF Diagnostics Holdings plc (OTCMKTS: EKDHF) is a global in vitro diagnostics company that develops, manufactures and markets a broad range of point-of-care and laboratory analyzers, reagents and consumables. The company’s product portfolio addresses key segments of the diagnostic testing market, including haematology, biochemistry, immunoassay, haemostasis and diabetes monitoring.

EKF Diagnostics offers peripheral blood analyzers designed for use in clinical laboratories, hospitals and veterinary clinics, along with handheld and benchtop devices for rapid on-site testing.

Featured Stories

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.